Cholesterol is a structural component of lipid rafts within the plasma membrane. These domains, used as platforms for various signaling molecules, regulate cellular processes including cell survival. Cholesterol contents are tightly correlated with the structure and function of lipid rafts. Liver X receptors (LXRs) have a central role in the regulation of cholesterol homeostasis within the cell. Therefore, we investigated whether these nuclear receptors could modulate lipid raft signaling and consequently alter prostate cancer (PCa) cell survival. Treatment with the synthetic LXR agonist T0901317 downregulated the AKT survival pathway and thus induced apoptosis of LNCaP PCa cells in both xenografted nude mice and cell culture. The decrease in tumor cholesterol content resulted from the upregulation of ABCG1 and the subsequent increase in reverse cholesterol transport. RNA interference experiments showed that these effects were mediated by LXRs. Atomic force microscopy scanning of the inner plasma membrane sheet showed smaller and thinner lipid rafts after LXR stimulation, associated with the downregulation of AKT phosphorylation in these lipid rafts. Replenishment of cell membranes with exogenous cholesterol antagonized these effects, showing that cholesterol is a key modulator in this process. Altogether, pharmacological modulation of LXR activity could thus reduce prostate tumor growth by enhancing apoptosis in a lipid raft-dependent manner.
Introduction
Prostate cancer (PCa) is the most frequently diagnosed cancer and the leading cause of death from cancer in men over the age of 50 years. Among the various genetic and environmental risk factors, epidemiological analyses have revealed a positive association between hypercholesterolemia and the development of PCa (Bravi et al., 2006; Magura et al., 2008) . It is well known that cancer cells produce more cholesterol and sphingolipids than do normal cells, especially in solid tumors (White, 1909; Swyer, 1942) . This phenomenon has been explained by the rapidly proliferating cancer cells requiring new components to build de novo plasma membrane. In agreement with this, statins, a class of HMG-CoA reductase inhibitors, and their derivatives block PCa cell growth in vitro (Ukomadu and Dutta, 2003; Mo and Elson, 2004) and have been suspected to have benefits in PCa progression in patients undergoing long-term treatment (Shannon et al., 2005; Murtola et al., 2008) .
Extensive studies on lipid rafts have underlined the crucial role of free cholesterol present in plasma membranes in raft-dependent signaling. Lipid rafts are characterized by liquid-ordered microdomains enriched in phospholipids and sphingolipids with highly saturated hydrocarbon chains (Simons and Toomre, 2000) . Cholesterol is an important component of lipid rafts and is proposed to induce their coalescence and thus to determine the size of raft platforms (Solomon et al., 1996; Lawrence et al., 2003; Freeman and Solomon, 2004) . This last point seems to be an important step in the distribution of membrane-associated proteins, in particular those involved in transduction signaling such as AKT/PKB. High levels of phosphorylated AKT protein, which has a crucial role in cell survival signaling, have been correlated with Gleason score (Liao et al., 2003) and associated with resistance to chemotherapy (Yuan and Whang, 2002) . Consistent with this, LNCaP xenografts in athymic mice showed that both phospho-signaling and apoptotic resistance were strengthened by a cholesterol-rich diet (Zhuang et al., 2005) , pointing out the crucial role of cholesterol in cell apoptosis resistance and cancer development.
Liver X receptor-a (LXRa) (NR1H3) and LXRb (NR1H2) belong to the nuclear receptor superfamily, bind to naturally occurring oxidized forms of cholesterol, known as oxysterols, and stimulate expression of target genes essentially involved in lipid metabolism (Tontonoz and Mangelsdorf, 2003; Volle and Lobaccaro, 2007) . Investigation of lxr knockout mice revealed prostatic stromal hyperplasia (Kim et al., 2009) . LXR activation by synthetic ligands such as T0901317 can repress growth of human prostatic cell lines in vitro and slow down tumoral prostatic cell xenograft expansion in vivo (Fukuchi et al., 2004b) . Given that LXRs are involved in cholesterol metabolism and that cholesterol has a crucial role in tumor development, we examined the effects of LXR ligands on LNCaP cells in vitro and in vivo in xenografted mice. We focused our investigations on lipid raft topography, AKT raftdependent transduction pathway and apoptosis. We found that LXR activation resulted in stimulation of apoptosis that occurred after raft disruption and AKT dephosphorylation.
Results

LXR activation induces apoptosis by inhibition of the AKT survival pathway through an indirect mechanism
Cell death regulation is a key process in PCa development. We thus analyzed the effect of LXR agonist treatments on LNCaP apoptosis. LNCaP cells were treated for 72 h with increasing amounts of T0901317, 22(R)-hydroxycholesterol, 25(R)-hydroxycholesterol and 7a-hydroxycholesterol. All LXR ligands increased the subG1 nuclei fraction from 20 to 85% (Figure 1a ). Even 7a-hydroxycholesterol, known to be a weak LXR agonist, significantly enhanced accumulation of subG1 nuclei. To determine which LXR isoform was involved and to confirm that apoptosis was mediated by LXRs, we silenced either LXRa or LXRb using small interfering RNAs for each endogenous isoform (Figure 1b ). LXRa and/or LXRb knockdown significantly reduced accumulation of subG1 nuclei induced by T0901317. This showed that the effect of T0901317 was mediated by LXRs and that both isoforms were involved in induction of apoptosis (Figure 1c) . Hence, in the following experiments we only used the T0901317 agonist to investigate LXR activation. Accumulation of cleaved caspases 3, 6, 9 and cleaved form of poly-ADP-ribosyl-polymerase indicated that T0901317 treatment activated cell death through the canonical apoptotic pathway (Figure 1d ).
We next analyzed the effect of LXR activation in vivo on the basis of the growth of xenografted LNCaP cells. As previously described (Fukuchi et al., 2004b) , T0901317-treated mice showed a significantly slower tumor growth without any effect on the body weight ( Figure 2a ). Decrease in tumor growth was confirmed by xenograft analysis during necropsy (Supplementary Data 1). TdT-mediated dUTP nick end labeling assay showed that the apoptotic cell index was significantly increased in tumors from T0901317-treated mice compared with vehicle-treated mice (Figure 2b ). Nevertheless, even T0901317-treated xenografts exhibit more apoptotic staining (Figure 2b) , and there is no correlation between the volume of the xenograft and the apoptotic index (data not shown). This indicates that T0901317 reduced xenograft growth not only by targeting apoptosis but also by other processes such as proliferation (Fukuchi et al., 2004b; Chuu et al., 2006) or angiogenesis (Walczak et al., 2004; Mouzat et al., 2009) . PCa cells are characterized by a strong resistance to apoptosis involving deregulation of various key cell survival transduction pathways such as AKT signaling. LNCaP cells exhibit PTEN inactivation, leading to constitutive activation of the AKT pathway (Carson et al., 1999) . We analyzed AKT phosphorylation on Ser 473 as a marker of AKT activation in LNCaP xenografts. As observed in Figure 2c , AKT survival pathway was inhibited in apoptotic areas strongly suggesting that this event was concomitant with apoptotic program activation.
To investigate the relationship between LXRs, AKT and apoptosis, a time course experiment was performed with T0901317 on LNCaP cell cultures. SubG1 nuclei (Figure 3c ). We concluded that LXRs induced apoptosis in part through a downregulation of the AKT cell survival signaling pathway in LNCaP cell cultures and xenografts, and presumably using an indirect mechanism.
LXRs stimulate cholesterol efflux through ABCG1 upregulation Cholesterol is known to stimulate AKT phosphorylation (Zhuang et al., 2005) . We therefore evaluated whether the effect of LXR activation on AKT signaling could be mediated by the modulation of the intracellular cholesterol contents. Cholesterol transporters ABCA1 and ABCG1 expression levels were analyzed by quantitative PCR and western blot. T0901317 treatment for 72 h induced ABCG1 but not ABCA1 mRNA and protein accumulation levels in LNCaP cells (Figure 4a ). Time course analysis showed an increase in ABCG1 accumulation after 8 h of treatment (Figure 4b ; Supplementary Data 2). Similar results were obtained from LNCaP xenografts: abcg1 expression level exhibited a 2.7-fold increase, whereas abca1 expression remained unchanged ( Figure 4c ). This upregulation was confirmed by immunohistochemistry for ABCG1 in xenografts ( Figure 4d ). Increase in ABCG1 expression strongly suggested that intracellular cholesterol concentration was reduced in T0901317-treated cells.
To confirm this hypothesis, free cholesterol levels were determined during a time course experiment in the presence of T0901317 in LNCaP cells. A significant and stable decrease in free cholesterol concentration was observed starting at 16 h (Figure 5a ), which was consistent with earlier accumulation of abcg1 at 8 h ( Figure 4b and Supplementary Data 2). Increased cholesterol accumulation in the T0901317-treated cell culture supernatant indicated an increase in the cholesterol efflux (Figure 5b ). Levels of both cholesterol esters and free cholesterol decreased in T0901317-treated mice tumors ( Figure 5c ). This decrease was correlated with the reverse cholesterol transport to the liver as indicated by higher total and high-density lipoprotein-cholesterol levels in the plasma of T0901317-treated mice ( Figure 5d ). Taken together, these results showed that LXRs stimulated early cholesterol efflux through ABCG1 transporter upregulation, which resulted in a subsequent inactivation of AKT pathways and stimulation of apoptosis.
LXR activation reduces lipid raft size in a cholesteroldependent manner Given that free cholesterol is the main component of lipid raft, we suspected that reduction of free cholesterol content in T0901317-treated cells could decrease the lipid raft domain size and subsequent downregulate AKT signaling. To confirm this hypothesis, we examined the topography of the inner membrane sheet of LNCaP cells using atomic force microscopy (AFM) to analyze membrane domain height and width. In control cells, membrane domains were abundant. Most of them displayed flotillin-2 staining (Figure 6a , top), indicating that they were lipid rafts. Repeated measurements, summarized in Figure 6b , revealed that, in dimethylsulfoxide (DMSO) conditions, the width and height of these domains range from 451±126 and 52±12 nm, respectively. These observations were consistent with previous studies on RBL-2H3 cells (Frankel et al., 2006) . Interdomain membrane regions had an average thickness of B7 nm, measured relative to the poly-L-lysine-coated substrate, thus corresponding to the phospholipid bilayer (Supplementary Data 3A) . T0901317 treatment resulted in a dispersion of both membrane domains and flotillin-2 staining, thus leading to membrane flattening (Figure 6a , bottom). Given that flotillin-2 is a raft resident protein, the decrease in its signal indicates raft dispersion in T0901317 conditions and strongly suggests structural changes in lipid rafts. Quantification of membrane domain sizes revealed that T0901317-treated cells harbored smaller domains compared with DMSOtreated cells regarding both width and height (Figure 6b , Supplementary Data 3B). Although domains exhibited a median width of 451 ± 126 nm and height of 52 ± 12 nm in DMSO conditions, T0901317 stimulation resulted in a reduction in size domains, 259 ± 88 for width and 24 ± 10 for height. These alterations were reversed by cotreatment with cholesterol with a width range of 512±122 and a height range of 46±18 nm. This emphasized that cholesterol was the central component by which LXRs could modulate the size of raft domains. Interestingly, cholesterol alone was also able to increase domain height (89 ± 26 vs 52 ± 12 nm) but did not appear to significantly alter domain width. Taken together, these results showed that LXR activation inhibited lipid raft coalescence by a mechanism involving cholesterol efflux.
Lipid raft alteration by LXRs blocks the AKT raft-dependent survival pathway Raft coalescence is tightly associated with survival signaling transduction (Freeman and Solomon, 2004) . For this reason, we investigated the raft-dependent signaling pathway phosphoinositide-3 kinase/AKT as a marker of survival signals inside lipid rafts. Lipid rafts were isolated by sucrose gradient ultracentrifugation (Supplementary Data 4). Enrichment and contamination of cytosol/membrane and raft fractions were analyzed by flotillin-2 and b-tubulin detection. T0901317 treatment for 24 h dramatically decreased AKT phosphorylation in the raft fraction, whereas AKT phosphorylation was unaltered in the cytosolic and membrane fractions (Figure 7 ). This slowing of AKT phosphorylation in the lipid raft fraction was consistent with the timing of the membrane cholesterol depletion observed (Figure 5a ) after 16 h of T0901317 induction.
Cholesterol antagonizes LXR-induced apoptosis by reactivation of the AKT survival pathway in lipid raft
We showed that cholesterol addition prevented raft disruption in T0901317-treated cells (Figure 6b ). Thus, we hypothesized that, by maintaining AKT signaling activity in lipid rafts, cholesterol supplementation could antagonize LXR-induced apoptosis. We investigated phosphoAKT Ser 473 and flotillin-2 subcellular localization by confocal microscopy. In control conditions, phosphoAKT Ser 473 colocalized with lipid rafts as shown by flotillin-2 staining (Figure 8a ), whereas T0901317 treatment decreased phosphoAKT Ser 473 signal within the plasma membrane. Cholesterol supplementation restored the localization of phosphoAKT Ser 473 within the rafts (see 'colocalization' column on Figure 8a ). In parallel, western blot analysis indicated that cholesterol addition partially prevented AKT dephosphorylation on Ser
473
, reduced accumulation of cleaved poly-ADP-ribosyl-polymerase (Figure 8b ) and reversed the effect of T0901317 on sub-G1 nuclei accumulation (Figure 8c) . Altogether, these results showed that the proapoptotic effects of activated LXRs were mediated by cholesterol depletion in rafts, which in turn inhibited activity of the AKT survival pathway and induced apoptosis.
Discussion
This study points out LXR isoforms and their ligands as key modulators of PCa cell survival. Our in vitro and in vivo analyses revealed that modulation of LXR activity triggered apoptosis of PCa cells. This effect involves both the increase in cholesterol efflux and the subsequent disruption of lipid rafts. We showed that LXR-mediated upregulation of ABCG1 stimulated reverse cholesterol transport. This resulted in a reduction in plasma membrane cholesterol steady-state levels. These observations were correlated with a decrease in the phosphorylated fraction of raft-associated AKT. We showed that cholesterol replenishment or MyrAKT expression prevented the cells from apoptosis in the presence of T0901317. Consistent with this mechanism, chronic T0901317 treatment induces downregulation of AKT and stimulates apoptosis of LNCaP-derived tumors in xenografted mice.
The major finding of this work is the role of LXRs as modulators of lipid raft signaling. Freeman and Solomon (2004) proposed that a critical cholesterol concentration in the membrane was required to allow raft coalescence. Sequestration of 'oncogenic' signaling proteins in a restricted area through raft coalescence could enhance their activity by exclusion of negative regulators outside the rafts (Yang et al., 1998) . Moreover, expansion of the raft could tether AKT with upstream regulators such as DNA-dependent protein kinase. This kinase is known to be associated with the raft fraction and to phosphorylate AKT on ser 473 residue (Hill et al., 2002) . Transfecting LNCaP cells with MyrAKT partially, but not completely, blocked T0901317-induced apoptosis (Figure 3c ). Consistent with this, MyrAKT has been described to be overrepresented in lipid raft fractions indicating that myristoylation preferably anchored the kinase in rafts (Adam et al., 2007) . Similar to MyrAKT, the subpopulation of AKT, which is cholesterol sensitive (raft resident), has been shown to phosphorylate distinct substrates from those targeted by AKT located elsewhere in the cell. These substrates have been shown to support most of the prosurvival effects of AKT (Adam et al., 2007) . These observations could explain why MyrAKT expression failed to completely abolish apoptosis in T0901317-treated cells. Another possibility could be that LXR activation interferes with others raftdependent survival pathways and acts by an AKTindependent mechanism.
As previously shown, inhibition of de novo cholesterol synthesis by simvastatin results in a decrease in raftassociated AKT phosphorylation without a concomitant effect on other AKT protein fractions (Zhuang et al., 2005). We observed a similar effect of T0901317 on LNCaP cells and consequently postulated that activation of LXRs could hamper raft coalescence. Chemical or RNA interference inhibition of squalene synthase, which switches the mevalonate/isoprenoid pathway toward sterol biosynthesis, was shown to decrease cholesterol concentration within lipid rafts and to induce growth arrest and cell death in LNCaP cells . A potential target of raft dynamics modulation is the Hedgehog pathway. The Hegdehog receptor Patched and its positive regulator Smoothened localize to lipid rafts and this complex can be altered by depletion of membrane cholesterol (Karpen et al., 2001 
Sanchez et al., 2004). Covalent binding of choles-
terol to the Hedgehog family signaling molecules is essential for pathway activity. Moreover, oxysterols have been reported to stimulate expression of two direct target genes of the Hedgehog pathway, gliomaassociated oncogene homolog 1 and patched (Dwyer et al., 2007) . Fukuchi et al (2004b) reported the control of cell proliferation by LXRs. In their experiments, T0901317 decreased the percentage of cells in the S phase through an upregulation of p27kip1. The induction of ABCA1 expression by T0901317 led to the assumption that ABCA1 was the key regulator of the cell cycle in response to LXR activation (Fukuchi et al., 2004a) . We observed induction of ABCG1 but not of ABCA1 in treated cells. Despite that difference, cholesterol efflux seems to be the common mechanism targeted by LXRs in both cases. This hypothesis was supported by experiments where cholesterol complementation prevented apoptosis of cells treated with T0901317 (Figure 8 ). This was further substantiated by the effect of methyl-b cyclodextrin, a cholesterol-depleting agent, which induces raft disruption and inactivation of AKT signaling (Li et al., 2006) .
Beyond LXR activation, oxysterols are also known to regulate apoptosis in various tissues. It is noted that 25-OHC and 7-ketocholesterol induce macrophage apoptosis by targeting AKT degradation. This degradation stimulates the cleavage of mitochondrial BCL family proteins involved in apoptosis through cytoplasmic cytochrome c release (Yang and Sinensky, 2000; Rusinol et al., 2004) . Oxysterols have also been identified as inducing apoptosis in a wide range of models such as human leukemia cell lines (Laffitte et al., 2003) or pancreatic b-cells (Choe et al., 2007; Meng et al., 2009) . In these cells, the master lipogenic genes SREBP1c, fatty acid synthase and acyl CoA-carboxylase-a drive an increase in intracellular lipid accumulation, which results in cell lipotoxicity. Paradoxically, PCa cells exhibit a high activation of the lipogenic pathway, which stimulates growth and proliferation. Accordingly, lipogenic enzymes have been found to be overexpressed in the earliest stages of PCa and in invasive carcinoma (Pizer et al., 2001; Swinnen et al., 2002; Rossi et al., 2003) . Likewise, inhibition of acyl CoA-carboxylase-a by soraphen A as well as RNA interference against acyl CoA-carboxylase-a or fatty acid synthase induces growth inhibition and apoptosis (Brusselmans et al., 2005; Beckers et al., 2007) . Production of long-chain fatty acids is thus required for cancer cell promotion. Altogether, these observations indicate that PCa progression is tightly linked to the activation of lipogenesis and concomitant inhibition of cholesterol efflux.
Our data raise the question of the role of circulating cholesterol levels in PCa progression. Epidemiological analyses revealed a positive association between hypercholesterolemia and PCa (Bravi et al., 2006; Magura et al., 2008) . In vitro, statins and their derivatives block PCa cell growth (Ukomadu and Dutta, 2003; Mo and Elson, 2004; Sekine et al., 2008) . Observational studies show a decreased risk of advanced PCa in patients using statins depending on the duration and dosage of the treatment (Demierre et al., 2005; Poynter et al., 2005; Shannon et al., 2005; Murtola et al., 2008) . Thus, our present study highlights LXR agonists as potent mediators to stimulate cholesterol reverse transport and subsequently to lower cholesterol supply in PCa cells. As already described for statins, decreasing free cholesterol within the cell appears to be a promising way to control prostatic tumor cell survival. Given that reverse cholesterol transport induced by LXRs results in the disruption of lipid rafts and downregulates raft-associated signaling in PCa cells, our findings reinforce the potential use of LXR agonists as pharmacological agents in cancer prevention and anticancer therapy.
Materials and methods
Reagents
The ligands 22(R)-hydroxycholesterol, 25(R)-hydroxycholesterol and 7a-hydroxycholesterol were purchased from SigmaAldrich (L'Isle d'Abeau, France), and T0901317 from Cayman Chemical (Montigny-le-Bretonneux, France). All the ligands used in the cell culture were diluted in DMSO. Water-soluble cholesterol was purchased from Sigma-Aldrich.
Cell culture and transfection LNCaP cells were cultured at 37 1C in 5% CO 2 atmosphere in RPMI medium (Invitrogen, Cergy Pontoise, France) containing penicillin and streptomycin (100 mg/ml) supplemented with 10% fetal bovine serum (Biowest, Nuaille´, France). For LXR RNA interference, LNCaP cells were transfected twice using the Metafecten transfectant reagent (Biontex Martinsried, Planegg, Germany) in 10% fetal bovine serum-supplemented medium with a single 400 pmol/ml small interfering RNA solution alone or in combination during 72 h. Cells were trypsinized and seeded at 2 Â 10 5 in six-well plates. After 12 h, cells were incubated in a fetal bovine serum-depleted medium containing a DMSO or T0901317 solution for 36 h. To silence genes, the following primers were used: siLXRa 5 0 -AGCA GGGCUGCAAGUGGAATT-3 0 ; siLXRb 5 0 -CAGAUCCGG AAGAAGAAGATT-3 0 ; siGFP 5 0 -ACUACCAGCAGAACA CCCCUUTT-3 0 . Cells were harvested and protein extraction or flow cytometry analyses were performed. For Myr AKT expression, 12 h after seeding at 2 Â 10 5 cells in six-well plates, cells were transfected using Metafecten with 1 mg of the pCMV6-HA-myrAKT vector (kindly provided by Dr Nahed N Ahmed (Ahmed et al., 1997) ). After 5 h of transfection, cells were treated for 48 h with 3 mM of T0901317 and the sub-G1 nuclei level analyzed by flow cytometry.
Western blot analysis
Proteins were extracted in HEPES 20 mM, NaCl 0.42 M, MgCl 2 1.5 mM, EDTA 0.2 mM, NP40 1%, phenylmethylsulfonyl fluoride 1 mM, Na 3 VO 4 0.1 mM, NaF 0.1 mM and complete 1X (Roche Diagnostics, Meylan, France). Lysates were centrifuged at 4 1C for 15 min at 15000 g. Forty mg of total protein were subjected to denaturing SDS-polyacrylamide gel electrophoresis and transferred to nitrocellulose membrane (Hybond-ECL, GE Healthcare, Uppsala, Sweden). Membranes were incubated overnight at 4 1C with primary polyclonal antibodies raised against either human anti-ABCA1 or ABCG1 (Novus Biologicals, Littleton, CO, USA), b-actin or b-tubulin (Sigma-Aldrich), AKT, caspase-3, cleaved-caspase-3, caspase-6, cleaved caspase-6, caspase-9 and cleaved caspase-9 (Cell Signaling, Montigny-le-Bretonneux, France), endothelial growth factor receptor (Thermo Fisher Scientific, Courtaboeuf, France), Flotillin-2/ESA (BD Transduction Laboratories, Le Pont de Claix, France), poly-ADP-ribosylpolymerase (Invitrogen), LXRa or LXRb (Perseus Proteomics, Tokyo, Japan) or Phospho-AKT (Epitomics, Burlingame, CA, USA). A second 1h-incubation with a peroxidase-conjugated anti-rabbit or mouse immunoglobulin G (P.A.R.I.S, Compie`gne, France) was performed. Peroxidase activity was detected with the Western Lightning System (Perkin-Elmer Life Sciences, Courtaboeuf, France).
Quantitative PCR Total RNA was isolated using Trizol reagent (Invitrogen) according to the manufacturer's instructions. cDNA was synthesized with MMLV-RT (Promega, Charbonnie`res, France) and random hexamer primers (Promega) according to the manufacturer's instructions. The quantitative PCR was performed on an iCycler (Bio-Rad, Marnes-la-coquette, France). Four ml of 1:50 diluted cDNA template were amplified by 0.75 U of HotMaster TaqDNA polymerase (Eppendorf, Brumath, France) using SYBR Green dye to measure duplex DNA formation. Primer sequences were as follows: ABCA1 5 0 -GCACTGAGGAAGATGCTGAA-3 0 and 5 0 -AGTTCCTGGAAGGTCTTGTTC-3 0 ; ABCG1 5 0 -CAGG AAGATTAGACACTGTG-3 0 and 5 0 -GAAAGGGGAATGG AGAGAAG-3 0 ; 36b4 5 0 -GTCACTGTGCCAGCTCAGAA-3 0 and 5 0 -TCAATGGTGCCTCTGGAGAT-3 0 . 36b4 was used as a housekeeping gene.
Cell immunofluorescence labeling
Cells were treated for 48 h with T0901317 or vehicle with or without cholesterol added for the last 24 h, rinsed three times in phosphate-buffered saline (PBS), and fixed in À20 1C methanol/acetone mixture (50/50: v/v) for 10 min. After rapid washes in PBS, cells were incubated in PBS Triton X-100 0.1% for 10 min. Anti-pAKT Ser473 (Epitomics) and/or antiFlotillin-2/ESA (BD Transduction Laboratories) immunochemistry was performed in 1.5% normal goat serum/PBS at 4 1C overnight. After washing, the secondary Alexa 555 conjugated anti-rabbit immunoglobulin G and/or Alexa 488 conjugated anti-mouse immunoglobulin G (Invitrogen) was added in 1.5% normal goat serum/PBS for 2 h at room temperature. Slides were mounted with VECTASHIELD (Vector Laboratories, Burlingame, CA, USA) and were visualized by Zeiss LSM 510 Meta Confocal microscope (Carl Zeiss, Le Pecq, France).
Xenograft immunostaining and TdT-mediated dUTP nick end labeling analysis Xenograft immunostaining was performed as follows: paraffin sections were dewaxed and rehydrated through a graded series of ethanol and double distilled water baths. Tissue sections were incubated in 0.1 M citrate buffer pH 6.0 for 5 min in microwave at 350 W. Unspecific epitopes were saturated using bovine serum albumin 1%, fetal bovine serum 1% diluted in PBS 1X at room temperature. Primary antibodies were diluted in PBS 1X, bovine serum albumin 0.1% and incubated at 4 1C overnight. Secondary Alexa 555 conjugated anti-rabbit immunoglobulin G (Invitrogen) was incubated 1 h at room temperature. To identify apoptosis in tumor sections, TdT-mediated dUTP nick end labeling method was applied using the In Situ Cell Death Detection Kit (Roche Diagnostics). Cell nuclei staining was obtained using Hoechst 33342 (Sigma-Aldrich) at 1 mg/ml. Picture analysis was performed using a Zeiss Axioplan fluorescence microscope. For apoptotic quantification, the ratio of apoptotic cells to total cells was measured by a threshold method using Image J 1.37v software (NIH, Bethesda, MD, USA).
Flow cytometry analysis
Cells were recovered and washed in PBS. Pellets were resuspended in RNase A (500 mg/ml), propidium iodide (50 mg/ml) solution and kept 1 h at 4 1C in the dark. Cell suspensions were analyzed using a Beckman Coulter fluorescence-activated cell sorter (Beckman Coulter, Roissy, France). The percentage of apoptotic cells was determined by evaluating sub-G1 nuclei accumulation. At least 15 000 events were measured for each sample.
Lipid analysis
Lipids were extracted as previously described (Grizard et al., 2000) . Blood concentrations of triglycerides, cholesterol, lowdensity lipoprotein cholesterol and high-density lipoprotein cholesterol were determined on an automated clinical chemistry analyzer (Roche Diagnostics) according to the manufacturer's instructions.
Lipid raft analysis
Membrane lipid rafts were isolated by ultracentrifugation on sucrose gradients. Cells were washed twice in PBS, scraped into 350 ml of TNE-Triton X-100 1% buffer (10 mM TRIS, 150 mM NaCl and 5 mM EDTA). After 5 s of sonication, 2 mg of protein were mixed with 85% sucrose in TNE buffer. A discontinuous sucrose gradient in TNE buffer was then formed by sequential layering, 42,5, 35 and 5% sucrose. Tubes were subjected to ultracentrifugation at 3 00 000 g for 19 h in Beckman Coulter Optima LE-80K swinging rotor SW 40Ti (Beckman) at 4 1C. Eleven fractions were collected from the top of the gradient. Samples were concentrated by methanol/ chloroform precipitation (Wessel and Flugge, 1984) and analyzed by western blotting.
Athymic nude mice study Six-to 8-week-old male Swiss nu/nu mice (Charles River, Chatillon-sur-Chalaronne, France) received subcutaneous injections of 3.10 6 LNCaP cells suspended in Matrigel (BD Bioscience). Three weeks after tumor implantation, either T0901317 or methyl-cellulose vehicle was daily per os administered during 1 month. Tumors were measured every 3 days using a caliper, and their volumes were calculated using the formula length Â width Â height Â 0.52 (Umekita et al., 1996) . Initial tumor volumes were 181 ± 74 mm 3 before treatment. Mice were killed after 1-month treatment. Xenografts were removed and divided into several parts: one was fixed in an ethanol, formaldehyde 37% and acetic acid mixture (7.5:2:0.5; v/v) and embedded in paraffin for histological analysis, and others were snap-frozen in liquid nitrogen for lipid and RNA analyses. Blood plasma samples were obtained just before necropsy by heart puncture on anesthetized mice. All animals were maintained in a controlled environment and animal care was conducted in compliance with the national standards and policies (C 63 014.19). All experiments were approved by the Regional Ethics Committee (protocol CE11-08).
Preparation of plasma membrane sheets for atomic force microscopy/fluorescence Plasma membranes were prepared as previously described (Frankel et al., 2006) . Briefly, cleaned glass coverslips were coated with 0.2 mg/ml of poly-L-lysine for 30 min. Living cells were fixed in 0.5% paraformaldehyde in PBS in the presence of Hoechst 33942 for 10 min in the dark at room temperature. The monolayer of cells was inverted and applied onto the coated coverslip in the presence of HEPES buffer (25 mM Hepes pH 7, 25 mM KCl) for 10 min at room temperature in a wet atmosphere to make a 'sandwich.' Coverslips were then separated by flotation, producing a monolayer of membrane sheets, all oriented with the cytoplasmic face-up for simultaneous AFM/fluorescence imaging. Before AFM and fluorescence analyses, flotillin-2 was detected as described above.
Simultaneous AFM and fluorescence imaging Atomic force microscopy was performed using a commercial AFM Bioscope (Nanoscope IIIa, Digital Instruments, Veeco, Santa Barbara, CA, USA) combined with an inverted optical microscope (Olympus IX 70, Rungis, France) and a fluorescence setup (Leica Camera DFC500, Leica Microsysteme, Nanterre, France). The coverslips with membrane sheets were mounted on a manual XY stage that allowed large range viewing of the sample with an Hg lamp. AFM was operated in contact mode in PBS using a long V-shape silicon nitride cantilever (320 mm in length), with a nominal spring constant of 0.01 mN/m (MLCT-AU microlevers, Veeco) to minimize the force applied to the sample (o1 nN). The image fields (20 Â 20 mm) were obtained at 0.5 Hz; thus, 5-10 min were required to scan the entire sample. The heights and widths of the domains were determined from the AFM topography images using the line profiling routines in Nanoscope software (v5.12, Veeco). The heights of domains (n ¼ 30) were measured relative to the surrounding membrane, not relative to the substrate.
Statistical analysis
Student's t-test or Mann-Whitney's test was performed to determine whether there were significant differences between the groups. A P-value o0.05 was considered significant.
